FMO5 and obesity disorder: With HFD consumption, elevated expression of NADPH oxidase, which is a major source of ROS, is present in the hypothalamus, while ablation of hypothalamic p22phox, the activator of NADPH oxidase, is protective against HFD-induced obesity [47].